Gerassimos E. Voutsinas

1.7k total citations
50 papers, 1.1k citations indexed

About

Gerassimos E. Voutsinas is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Gerassimos E. Voutsinas has authored 50 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 39 papers in Molecular Biology, 12 papers in Oncology and 10 papers in Surgery. Recurrent topics in Gerassimos E. Voutsinas's work include Cancer-related Molecular Pathways (9 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Cell death mechanisms and regulation (5 papers). Gerassimos E. Voutsinas is often cited by papers focused on Cancer-related Molecular Pathways (9 papers), Bladder and Urothelial Cancer Treatments (7 papers) and Cell death mechanisms and regulation (5 papers). Gerassimos E. Voutsinas collaborates with scholars based in Greece, United States and Czechia. Gerassimos E. Voutsinas's co-authors include Dimitrios J. Stravopodis, Lukas H. Margaritis, Sofia Tseleni‐Balafouta, Galinos Fanourakis, Nicholas Mitsiades, Constantine S. Mitsiades, Eumorphia G. Konstantakou, Vassiliki Poulaki, A. Kappas and Efstratios Patsouris and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Scientific Reports.

In The Last Decade

Gerassimos E. Voutsinas

48 papers receiving 1.1k citations

Peers

Countries citing papers authored by Gerassimos E. Voutsinas

Since Specialization

Citations

This map shows the geographic impact of Gerassimos E. Voutsinas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerassimos E. Voutsinas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerassimos E. Voutsinas more than expected).

Fields of papers citing papers by Gerassimos E. Voutsinas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerassimos E. Voutsinas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerassimos E. Voutsinas. The network helps show where Gerassimos E. Voutsinas may publish in the future.

Co-authorship network of co-authors of Gerassimos E. Voutsinas

This figure shows the co-authorship network connecting the top 25 collaborators of Gerassimos E. Voutsinas. A scholar is included among the top collaborators of Gerassimos E. Voutsinas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerassimos E. Voutsinas. Gerassimos E. Voutsinas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Non-Canonical Compartmentalization of DROSHA Protein at the Golgi Apparatus: miRNA Biogenesis-Independent Functionality in Human Cancer Cells of Diverse Tissue Origin 2025 ·International Journal of Molecular Sciences ·(unknown), (unknown), Kostas A. Papavassiliou, (unknown), (unknown), Efthimia K. Basdra, Athanasios G. Papavassiliou, Ourania Tsitsilonis, Gerassimos E. Voutsinas, Athanassios D. Velentzas, Ema Anastasiadou, Dimitrios J. Stravopodis	0
2	Microtubule Dynamics Deregulation Induces Apoptosis in Human Urothelial Bladder Cancer Cells via a p53-Independent Pathway 2023 ·Cancers ·Yiannis Drosos, Eumorphia G. Konstantakou, (unknown), (unknown), (unknown), S. Markaki, Ourania Tsitsilonis, Gerassimos E. Voutsinas, (unknown), Ema Anastasiadou, Dimitris Thanos, Athanassios D. Velentzas, Dimitrios J. Stravopodis	4
3	Mitochondrial p38 Mitogen-Activated Protein Kinase: Insights into Its Regulation of and Role in LONP1-Deficient Nematodes 2023 ·International Journal of Molecular Sciences ·(unknown), Eleni Kyriakou, (unknown), (unknown), (unknown), Stamatis Rigas, Gerassimos E. Voutsinas, Popi Syntichaki	2
4	Malignancy Grade-Dependent Mapping of Metabolic Landscapes in Human Urothelial Bladder Cancer: Identification of Novel, Diagnostic, and Druggable Biomarkers 2020 ·International Journal of Molecular Sciences ·(unknown), (unknown), (unknown), Dimitra Benaki, (unknown), Athanassios D. Velentzas, Ourania Tsitsilonis, Issidora S. Papassideri, Gerassimos E. Voutsinas, Eumorphia G. Konstantakou, Evagelos Gikas, Emmanuel Mikros, Dimitrios J. Stravopodis	8
5	Resistance to Fas-Mediated Apoptosis Does Not Correlate to Structural Alterations or Expression Changes of the Death Receptor in Papillary Thyroid Carcinomas 2018 ·Pathobiology ·(unknown), Angelica A. Saetta, Andreas C. Lazaris, (unknown), Gerassimos E. Voutsinas, Efstratios Patsouris, Sofia Tseleni‐Balafouta	1
6	Deep-proteome mapping of WM-266-4 human metastatic melanoma cells: From oncogenic addiction to druggable targets 2017 ·PLoS ONE ·Eumorphia G. Konstantakou, Athanassios D. Velentzas, Athanasios K. Anagnostopoulos, Zoi I. Litou, (unknown), (unknown), Ema Anastasiadou, Gerassimos E. Voutsinas, George Th. Tsangaris, Dimitrios J. Stravopodis	21
7	Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece 2017 ·Scientific Reports ·(unknown), Florentia Fostira, (unknown), (unknown), (unknown), Radek Vodička, Radek Vrtěl, (unknown), Dimitrios J. Stravopodis, Metaxia Vlassi, Aristotelis Astrinidis, Drakoulis Yannoukakos, Gerassimos E. Voutsinas	23
8	Prevalence of BRCA1 Mutations in Familial and Sporadic Greek Ovarian Cancer Cases 2013 ·PLoS ONE ·Alexandra Stavropoulou, Florentia Fostira, Maroulio Pertesi, (unknown), Gerassimos E. Voutsinas, Olga Triantafyllidou, Aristotelis Bamias, Meletios Α. Dimopoulos, Eleni Timotheadou, Dimitrios Pectasides, Christos Christodoulou, G. Klouvas, Christos Papadimitriou, Thomas Makatsoris, George Pentheroudakis, Gerasimos Aravantinos, (unknown), Drakoulis Yannoukakos, George Fountzilas, Irene Konstantopoulou	26
9	Targeted inhibition of heat shock protein 90 disrupts multiple oncogenic signaling pathways, thus inducing cell cycle arrest and programmed cell death in human urinary bladder cancer cell lines 2013 ·Cancer Cell International ·(unknown), Dimitrios J. Stravopodis, Eumorphia G. Konstantakou, Gerassimos E. Voutsinas	31
10	The resurgence of Hormone-Sensitive Lipase (HSL) in mammalian lipolysis 2011 ·Gene ·(unknown), (unknown), Gerassimos E. Voutsinas, Dimitrios J. Stravopodis	158
11	Mutational and Immunohistochemical Study of the PI3K/Akt Pathway in Papillary Thyroid Carcinoma in Greece 2010 ·Endocrine Pathology ·(unknown), (unknown), Gerassimos E. Voutsinas, Nicholas Mitsiades, (unknown), (unknown), Efstratios Patsouris, Sofia Tseleni‐Balafouta	13
12	17-Allylamino-17-demethoxygeldanamycin induces downregulation of critical Hsp90 protein clients and results in cell cycle arrest and apoptosis of human urinary bladder cancer cells 2010 ·BMC Cancer ·(unknown), Dimitrios J. Stravopodis, Lukas H. Margaritis, Gerassimos E. Voutsinas	49
13	Mutational analysis of the BRAF, RAS and EGFR genes in human adrenocortical carcinomas 2009 ·Endocrine Related Cancer ·Vassiliki Kotoula, (unknown), (unknown), Galinos Fanourakis, Triantafyllia Κoletsa, Gerassimos E. Voutsinas, Sofia Tseleni‐Balafouta, Constantine S. Mitsiades, Axel Wellmann, Nicholas Mitsiades	38
14	Drug-Mediated Targeted Disruption of Multiple Protein Activities Through Functional Inhibition of the Hsp90 Chaperone Complex 2007 ·Current Medicinal Chemistry ·Dimitrios J. Stravopodis, Lukas H. Margaritis, Gerassimos E. Voutsinas	62
15	Fibrillin expression and localization in various types of carcinomas of the thyroid gland 2006 ·Modern Pathology ·Sofia Tseleni‐Balafouta, Hariklia Gakiopoulou, Galinos Fanourakis, Gerassimos E. Voutsinas, (unknown), (unknown), (unknown), Efstratios Patsouris	12
16	Lack of Fas (APO-1/CD95) gene structural alterations or transcript variant ratio changes in breast cancer 2003 ·Cancer Letters ·(unknown), Eftichia Petrakou, (unknown), Aglaia Athanassiadou, (unknown), Adamantia Papachatzopoulou, Vassilis G. Gorgoulis, Athanassios Kotsinas, (unknown), George M. Maniatis, Gerassimos E. Voutsinas	6
17	Detection of genetic abnormalities in neoplasms from Greek patients with FAP 2003 ·European Journal of Surgical Oncology ·Nikolaos V. Michalopoulos, Angelica A. Saetta, Andreas C. Lazaris, Gerassimos E. Voutsinas, P Davaris	1
18	Antimutagenicity of three isomers of aminobenzoic acid in Salmonella typhimurium 1994 ·Mutation research. Fundamental and molecular mechanisms of mutagenesis ·T. Gichner, Gerassimos E. Voutsinas, (unknown), A. Kappas, Michael J. Plewa	15
19	Mutagenicity of four homo-aza-steroidal esters of m-N,N-bis(2-chloroethyl)aminocinnamic acid in the Ames test 1993 ·Mutation Research/Genetic Toxicology ·Gerassimos E. Voutsinas, A. Kappas, N.A. Demopoulos, (unknown)	0
20	Mutagenic activity of the antitumour agent homo-aza-steroidal ester of p-N,N-bis(2-chloroethyl)aminophenoxyacetic acid (NSC 294859) in the Salmonella/microsome assay 1993 ·Mutagenesis ·Gerassimos E. Voutsinas, A. Kappas, N.A. Demopoulos, P. CATSOULACOS	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact